ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,632.33
1.05%
Dow Jones
41,488.19
1.65%
Gold vs US Dollar
2,984.995
-0.06%
Brent Oil
70.285
0.00%
Bitcoin
84,018.11
-0.40%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Imunon Inc (IMNN)

  7. Imunon Inc (IMNN) News

Imunon (IMNN)

Imunon Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMNN
DateTimeSourceHeadlineSymbolCompany
27/02/202513:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:IMNNImunon Inc
27/02/202513:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
27/02/202513:05GlobeNewswire Inc.IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 StudyNASDAQ:IMNNImunon Inc
26/02/202513:05GlobeNewswire Inc.IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19NASDAQ:IMNNImunon Inc
20/02/202513:30GlobeNewswire Inc.IMUNON to Hold 2024 Financial Results and Business Update Conference Call on Thursday, February 27, 2025NASDAQ:IMNNImunon Inc
19/02/202521:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
19/02/202513:05GlobeNewswire Inc.IMUNON Announces Translational Data from Phase 1/2 OVATION 2 Study of IMNN-001 in Advanced Ovarian CancerNASDAQ:IMNNImunon Inc
18/02/202521:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
13/02/202518:50Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IMNNImunon Inc
10/02/202513:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
10/02/202513:05GlobeNewswire Inc.IMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer NASDAQ:IMNNImunon Inc
28/01/202521:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
19/12/202421:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
19/12/202413:05GlobeNewswire Inc.IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian CancerNASDAQ:IMNNImunon Inc
10/12/202413:05GlobeNewswire Inc.IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001NASDAQ:IMNNImunon Inc
27/11/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
25/11/202413:05GlobeNewswire Inc.IMUNON Announces Results from its End-of-Phase 2 Meeting with the FDA for its Lead IMNN-001 Clinical Program in Advanced Ovarian CancerNASDAQ:IMNNImunon Inc
14/11/202422:37Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:IMNNImunon Inc
14/11/202417:17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IMNNImunon Inc
07/11/202415:00GlobeNewswire Inc.IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual MeetingNASDAQ:IMNNImunon Inc
07/11/202414:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
07/11/202414:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMNNImunon Inc
07/11/202413:05GlobeNewswire Inc.IMUNON Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:IMNNImunon Inc
31/10/202423:57Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IMNNImunon Inc
31/10/202412:30GlobeNewswire Inc.IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024NASDAQ:IMNNImunon Inc
30/10/202413:05GlobeNewswire Inc.IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual MeetingNASDAQ:IMNNImunon Inc
08/10/202420:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
07/10/202412:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
07/10/202412:05GlobeNewswire Inc.IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IMNNImunon Inc
27/09/202420:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:IMNNImunon Inc
 Showing the most relevant articles for your search:NASDAQ:IMNN

Your Recent History

NYSE
ABBV
AbbVie
AMEX
CONY
Yieldmax Coin Option Inc...
USOTC
PCTL
PCT (CE)
BIT
P118U3
Bnp Paribas Issuance
NYSE
LANV
Lanvin
TG
NK1A
DNO ASA
NYSE
GGT-E
Gabelli Multimedia
TG
REB
Arafura Rare Earths
AMEX
UUUU
Energy Fuels
USOTC
PRPM
ProTek Capital (CE)
NASDAQ
MDB
MongoDB
BIT
S31846
Societe Generale Effekten
USOTC
ANTI
Antigenics (CE)
NYSE
VZIO
VIZIO
AMEX
NFRA
FlexShares STOXX Global ...
AMEX
XITK
SPDR Series
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads